Belvar, Wilson C.
HRN: 23-30-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2023
CLINDAMYCIN 300MG (CAP)
07/11/2023
07/17/2023
ORAL
300mg
TID
Soft Tissue Injury Secondary To Hack Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes